To amend the Controlled Substances Act to require the Drug Enforcement Administration to report certain information on distribution of opioids, and for other purposes.
Judiciary Committee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Using Data to Prevent Opioid Diversion Act of 2018 This bill establishes a new requirement intended to help drug manufacturers and distributors identify and prevent suspicious orders of opioids and reduce rates of diversion. Specifically, the Drug Enforcement Administration must use its automated data system—the Automated Reports and Consolidated Ordering System—to inform drug manufacturers and distributors about the quantity and type of opioids that are distributed to pharmacies and practitioners. Additionally, the bill establishes new requirements for reporting, collecting, and sharing information about suspicious orders.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Business recordsCivil actions and liabilityCongressional oversightCriminal investigation, prosecution, interrogationCriminal justice information and recordsDrug trafficking and controlled substancesGovernment information and archivesHealth personnelLicensing and registrationsRetail and wholesale tradesState and local government operations
To amend the Controlled Substances Act to require the Drug Enforcement Administration to report certain information on distribution of opioids, and for other purposes.
USA115th CongressHR-6779| House
| Updated: 9/12/2018
Using Data to Prevent Opioid Diversion Act of 2018 This bill establishes a new requirement intended to help drug manufacturers and distributors identify and prevent suspicious orders of opioids and reduce rates of diversion. Specifically, the Drug Enforcement Administration must use its automated data system—the Automated Reports and Consolidated Ordering System—to inform drug manufacturers and distributors about the quantity and type of opioids that are distributed to pharmacies and practitioners. Additionally, the bill establishes new requirements for reporting, collecting, and sharing information about suspicious orders.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Business recordsCivil actions and liabilityCongressional oversightCriminal investigation, prosecution, interrogationCriminal justice information and recordsDrug trafficking and controlled substancesGovernment information and archivesHealth personnelLicensing and registrationsRetail and wholesale tradesState and local government operations